Coenzyme Q10 and statin myalgia: What is the evidence?

Current Atherosclerosis Reports

Volumn 12, Issue 6, 2010, Pages 407-413

  Mas, Emilie ^a   Mori, Trevor A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Myalgia; Statins; Ubiquinone coenzyme Q10

Indexed keywords

ALPHA TOCOPHEROL; ATORVASTATIN; CHOLESTEROL; FENOFIBRATE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; UBIDECARENONE;

APOPTOSIS; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ABSORPTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GENETIC PREDISPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MYALGIA; MYOPATHY; MYOSITIS; NONHUMAN; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SUPPLEMENTATION;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCULAR DISEASES; UBIQUINONE;

EID: 77958196854     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0134-3     Document Type: Review

References (52)

1. SA Murphy CP Cannon SD Wiviott, et al. 2007 Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials) Am J Cardiol 100 1047 1051 1:CAS:528:DC%2BD2sXhtVOit73E 10.1016/j.amjcard.2007.04.053 17884359
2. P Thavendiranathan A Bagai MA Brookhart NK Choudhry 2006 Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials Arch Intern Med 166 2307 2313 1:CAS:528: DC%2BD2sXhtFGgtQ%3D%3D 10.1001/archinte.166.21.2307 17130382
3. RY Mukhtar JP Reckless 2005 Statin-induced myositis: a commonly encountered or rare side effect? Curr Opin Lipidol 16 640 647 1:CAS:528:DC%2BD2MXhtFymtbzN 16276242
4. KA Sewright PM Clarkson PD Thompson 2007 Statin myopathy: incidence, risk factors, and pathophysiology Curr Atheroscler Rep 9 389 396 1:CAS:528:DC%2BD2sXhtlOltbvL 10.1007/s11883-007-0050-3 18001622
5. RC Pasternak SC Smith Jr CN Bairey-Merz, et al. 2002 ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins Stroke 33 2337 2341 10.1161/01.str.0000034125.94759.41 12215610
6. PD Thompson PM Clarkson RS Rosenson 2006 An assessment of statin safety by muscle experts Am J Cardiol 97 69C 76C 1:CAS:528:DC%2BD28XkvF2gsro%3D 10.1016/j.amjcard.2005.12.013 16581332
7. SA Siddiqi PD Thompson 2009 How do you treat patients with myalgia who take statins? Curr Atheroscler Rep 11 9 14 1:CAS:528:DC%2BD1MXltVSks7k%3D 10.1007/s11883-009-0002-1 19080722
8. E Bruckert G Hayem S Dejager, et al. 2005 Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-the PRIMO study Cardiovasc Drugs Ther 19 403 414 1:CAS:528:DC%2BD28XhtlGku7w%3D 10.1007/s10557-005-5686-z 16453090
9. CV Venero PD Thompson 2009 Managing statin myopathy Endocrinol Metab Clin North Am 38 121 136 1:CAS:528:DC%2BD1MXkt1eks7w%3D 10.1016/j.ecl.2008.11.002 19217515
10. M Law AR Rudnicka 2006 Statin safety: a systematic review Am J Cardiol 97 52C 60C 1:CAS:528:DC%2BD28XkvF2gsr4%3D 10.1016/j.amjcard.2005.12.010 16581329
11. A Kashani CO Phillips JM Foody, et al. 2006 Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation 114 2788 2797 1:CAS:528:DC%2BD28Xht12ktbjI 10.1161/CIRCULATIONAHA.106.624890 17159064
12. HN Ginsberg MB Elam LC Lovato, et al. 2010 Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 1563 1574 10.1056/NEJMoa1001282 20228404
13. FL Crane Y Hatefi RL Lester C Widmer 1957 Isolation of a quinone from beef heart mitochondria Biochim Biophys Acta 25 220 221 1:CAS:528: DyaG2sXos1aitA%3D%3D 10.1016/0006-3002(57)90457-2 13445756
14. FL Crane 2001 Biochemical functions of coenzyme Q10 J Am Coll Nutr 20 591 598 1:CAS:528:DC%2BD38XmvVKqtA%3D%3D 11771674
15. M Turunen J Olsson G Dallner 2004 Metabolism and function of coenzyme Q Biochim Biophys Acta 1660 171 199 1:CAS:528:DC%2BD2cXntV2rtg%3D%3D 10.1016/j.bbamem.2003.11.012 14757233
16. Y Tomono J Hasegawa T Seki, et al. 1986 Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man Int J Clin Pharmacol Ther Toxicol 24 536 541 1:CAS:528:DyaL2sXhslenuw%3D%3D 3781673
17. M Tomasetti R Alleva MD Solenghi GP Littarru 1999 Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis Biofactors 9 231 240 1:CAS:528:DyaK1MXkt12msbg%3D 10.1002/biof.5520090218 10416035
18. JM Villalba C Parrado M Santos-Gonzalez FJ Alcain 2010 Therapeutic use of coenzyme Q(10) and coenzyme Q(10)-related compounds and formulations Expert Opin Investig Drugs 19 535 554 1:CAS:528:DC%2BC3cXkt1agtbc%3D 10.1517/13543781003727495 20367194
19. RA Willis K Folkers JL Tucker, et al. 1990 Lovastatin decreases coenzyme Q levels in rats Proc Natl Acad Sci U S A 87 8928 8930 1:CAS:528: DyaK3MXhsleqtA%3D%3D 10.1073/pnas.87.22.8928 2247467
20. K Folkers P Langsjoen R Willis, et al. 1990 Lovastatin decreases coenzyme Q levels in humans Proc Natl Acad Sci U S A 87 8931 8934 1:CAS:528: DyaK3MXhsleqtQ%3D%3D 10.1073/pnas.87.22.8931 2247468
21. Ashton E, Windebank E, Skiba M, et al.: Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study. Int J Cardiol 2010 (in press).
22. M Davidson J McKenney E Stein, et al. 1997 Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia Atorvastatin Study Group I. Am J Cardiol 79 1475 1481 1:CAS:528:DyaK2sXktF2jsLs%3D
23. G Ghirlanda A Oradei A Manto, et al. 1993 Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study J Clin Pharmacol 33 226 229 1:STN:280: DyaK3s3hs12ktw%3D%3D 8463436
24. GF Watts C Castelluccio C Rice-Evans, et al. 1993 Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin J Clin Pathol 46 1055 1057 1:STN:280:DyaK2c%2FnsFOjtA%3D%3D 10.1136/jcp.46.11.1055 8254097
25. JA Human JB Ubbink JJ Jerling, et al. 1997 The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia Clin Chim Acta 263 67 77 1:CAS:528:DyaK2sXktlCrtLs%3D 10.1016/S0009-8981(97) 06557-1 9247729
26. R Laaksonen K Jokelainen J Laakso, et al. 1996 The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle Am J Cardiol 77 851 854 1:CAS:528:DyaK28XjsFagsrc%3D 10.1016/S0002-9149(97)89180-1 8623738
27. R Laaksonen A Riihimaki J Laitila, et al. 1995 Serum and muscle tissue ubiquinone levels in healthy subjects J Lab Clin Med 125 517 521 1:CAS:528:DyaK2MXlsVChsrY%3D 7706908
28. H Mabuchi A Nohara J Kobayashi, et al. 2007 Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study Atherosclerosis 195 e182 189 1:CAS:528:DC%2BD2sXhtlahtbrF 10.1016/j.atherosclerosis.2007.06.010 17681347
29. GP Littarru P Langsjoen 2007 Coenzyme Q10 and statins: biochemical and clinical implications Mitochondrion 7 Suppl S168 174 1:CAS:528: DC%2BD2sXlt1aktrw%3D 10.1016/j.mito.2007.03.002 17482884
30. S Passi A Stancato E Aleo, et al. 2003 Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA Biofactors 18 113 124 1:CAS:528:DC%2BD3sXpsFenurg%3D 10.1002/biof.5520180213 14695926
31. BE Bleske RA Willis M Anthony, et al. 2001 The effect of pravastatin and atorvastatin on coenzyme Q10 Am Heart J 142 E2 1:STN:280:DC%2BD3MvltlCmtw%3D%3D 10.1067/mhj.2001.116762 11479481
32. L Marcoff PD Thompson 2007 The role of coenzyme Q10 in statin-associated myopathy: a systematic review J Am Coll Cardiol 49 2231 2237 1:CAS:528:DC%2BD2sXmtlWisrg%3D 10.1016/j.jacc.2007.02.049 17560286
33. P Low M Andersson C Edlund G Dallner 1992 Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat Biochim Biophys Acta 1165 102 109 1:STN:280:DyaK3s%2FktF2kuw%3D%3D 1420339
34. M Fukami N Maeda J Fukushige, et al. 1993 Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits Res Exp Med (Berl) 193 263 273 1:CAS:528:DyaK2cXitlGrsbs%3D 10.1007/BF02576234
35. WH Schaefer JW Lawrence AF Loughlin, et al. 2004 Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats Toxicol Appl Pharmacol 194 10 23 1:CAS:528: DC%2BD2cXjtFagsw%3D%3D 10.1016/j.taap.2003.08.013 14728975
36. R Laaksonen K Jokelainen T Sahi, et al. 1995 Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans Clin Pharmacol Ther 57 62 66 1:STN:280:DyaK2M7ivFejtA%3D%3D 10.1016/0009-9236(95)90266-X 7828383
37. H Paiva KM Thelen R Van Coster, et al. 2005 High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial Clin Pharmacol Ther 78 60 68 10.1016/j.clpt.2005.03.006 16003294
38. BA Schick R Laaksonen JJ Frohlich, et al. 2007 Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin Clin Pharmacol Ther 81 650 653 1:CAS:528:DC%2BD2sXlsFCqs7g%3D 10.1038/sj.clpt.6100124 17329991
39. P Sirvent J Mercier A Lacampagne 2008 New insights into mechanisms of statin-associated myotoxicity Curr Opin Pharmacol 8 333 338 1:CAS:528: DC%2BD1cXmvVyls7s%3D 10.1016/j.coph.2007.12.010 18243052
40. M Kobayashi T Kagawa K Narumi, et al. 2008 Bicarbonate supplementation as a preventive way in statins-induced muscle damage J Pharm Pharm Sci 11 1 8 1:CAS:528:DC%2BD1MXht1ClsLnN 18445360
41. BA Golomb MA Evans 2008 Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism Am J Cardiovasc Drugs 8 373 418 1:CAS:528:DC%2BD1MXjsVequr0%3D 10.2165/0129784-200808060-00004 19159124
42. S Sacconi E Trevisson L Salviati, et al. 2010 Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy Neuromuscul Disord 20 44 48 10.1016/j.nmd.2009.10.014 19945282
43. HB Levy HK Kohlhaas 2006 Considerations for supplementing with coenzyme Q10 during statin therapy Ann Pharmacother 40 290 294 1:CAS:528: DC%2BD28Xit1KisL0%3D 10.1345/aph.1G409 16449543
44. G De Pinieux P Chariot M Ammi-Said, et al. 1996 Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio Br J Clin Pharmacol 42 333 337 1:CAS:528:DyaK28XlvVGntrg%3D 10.1046/j.1365-2125.1996.04178.x 8877024
45. C Lamperti AB Naini V Lucchini, et al. 2005 Muscle coenzyme Q10 level in statin-related myopathy Arch Neurol 62 1709 1712 10.1001/archneur.62.11.1709 16286544
46. J Oh MR Ban BA Miskie, et al. 2007 Genetic determinants of statin intolerance Lipids Health Dis 6 7 10.1186/1476-511X-6-7 17376224
47. R Laaksonen M Katajamaa H Paiva, et al. 2006 A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle PLoS One 1 e97 10.1371/journal.pone. 0000097 17183729
48. TR Joy RA Hegele 2009 Narrative review: statin-related myopathy Ann Intern Med 150 858 868 19528564
49. TA Mori V Burke I Puddey, et al. 2009 The effects of omega-3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial J Hypertens 27 1863 1872 1:CAS:528: DC%2BD1MXhtVWhsr%2FN 10.1097/HJH.0b013e32832e1bd9 19705518
50. G Caso P Kelly MA McNurlan WE Lawson 2007 Effect of coenzyme q10 on myopathic symptoms in patients treated with statins Am J Cardiol 99 1409 1412 1:CAS:528:DC%2BD2sXlt1equr4%3D 10.1016/j.amjcard.2006.12.063 17493470
51. JM Young CM Florkowski SL Molyneux, et al. 2007 Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia Am J Cardiol 100 1400 1403 1:CAS:528:DC%2BD2sXhtF2itLbF 10.1016/j.amjcard.2007.06.030 17950797
52. CF Schaars AF Stalenhoef 2008 Effects of ubiquinone (coenzyme Q10) on myopathy in statin users Curr Opin Lipidol 19 553 557 1:CAS:528: DC%2BD1cXht12gu7rL 10.1097/MOL.0b013e3283168ecd 18957876